Manufacturers initiate rolling submission in US for long acting cabotegravir for prevention of HIV

This treatment is being investigated for pre-exposure prophylaxis in the Phase IIb/III HPTN 083 and HPTN 084 studies in which the randomised portion was stopped early as long acting cabotegravir was found to be superior to emtricitabine/tenofovir disoproxil fumarate.

Biospace Inc.